Last $11.00 USD
Change Today -0.10 / -0.90%
Volume 9.5K
MSLP On Other Exchanges
Symbol
Exchange
OTC US
Berlin
As of 5:20 PM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

muscle pharm corp (MSLP) Snapshot

Open
$11.00
Previous Close
$11.10
Day High
$11.40
Day Low
$10.90
52 Week High
08/8/13 - $13.10
52 Week Low
03/28/14 - $6.16
Market Cap
122.4M
Average Volume 10 Days
27.2K
EPS TTM
$-1.24
Shares Outstanding
11.1M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MUSCLE PHARM CORP (MSLP)

muscle pharm corp (MSLP) Related Bloomberg News

View More Bloomberg News

muscle pharm corp (MSLP) Related Businessweek News

No Related Businessweek News Found

muscle pharm corp (MSLP) Details

MusclePharm Corporation develops, manufactures, markets, and distributes branded nutritional supplements in the United States and internationally. It offers a range of powders, capsules, tablets, and gels. The company’s MusclePharm Hybrid series products include Assault, Amino1, and Combat Protein Powder; MusclePharm core products comprise BCAA 3:1:2, CLA Core, and Fish Oil that balance the essentials to meet the day-in and day-out demands of athletes; and Arnold Schwarzenegger series physique supplements consist of protein gainers, muscle builders, multivitamins, and nitric oxide boosters. It also provides FitMiss, which is designed and formulated primarily for women lifestyle to cover various needs, including weight loss, multi-vitamins, protein shakes, detox, skin care, and pre-workout energy mixes. In addition, the company offers over-the-counter drugs and preparations, and cosmetics, as well as licenses its apparel line. MusclePharm Corporation sells its products to various fitness enthusiasts, such as football, combat sports, weight training, bodybuilding, runners, basketball, and soccer, as well as cross fit, golf, tennis, volleyball, outdoor activities, and athletic and recreational enthusiasts. The company was founded in 2008 and is headquartered in Denver, Colorado.

93 Employees
Last Reported Date: 03/31/14
Founded in 2008

muscle pharm corp (MSLP) Top Compensated Officers

Co-Founder, Chairman and Chief Executive Offi...
Total Annual Compensation: $510.0K
President and Director
Total Annual Compensation: $413.0K
Co-Founder and Executive Vice President of Br...
Total Annual Compensation: $310.0K
President of Sales & Marketing
Total Annual Compensation: $450.0K
Advisor
Total Annual Compensation: $410.0K
Compensation as of Fiscal Year 2013.

muscle pharm corp (MSLP) Key Developments

MusclePharm Corporation Announces Results of Double-Blind Placebo-Controlled Clinical Study

MusclePharm Corporation announced that published the results of a double-blind placebo-controlled clinical study, which demonstrated that it's recovery and hydration supplement Amino1 enhanced rehydration more effectively than water and Gatorade. In this study, recreationally active men and women were dehydrated, and then given three separate rehydration beverages with equal volumes of Amino1, Gatorade or flavored water. The study showed that Amino1 rehydrated individuals significantly faster and more efficiently than Gatorade or water. After consuming Amino1, the test subjects returned to their normal hydration levels in four hours. The results of this study suggest that taking Amino1 can enhance and facilitate normal rehydration, allowing athletes to recover faster, and also help to maintain normal hydration levels during training or competition. Independent of the re-hydration results, the amino acids in Amino1 have been shown to help muscles recover from exercise, as well as prevent muscle breakdown during exercise, making Amino1 an ideal product for athletes to drink before, during, or after their workouts.

MusclePharm Corporation Appoints Gregory Macosko as Member of the Board of Directors and as Chairman of the Audit Committee

Effective June 23, 2014, the Board of Directors of MusclePharm Corporation appointed Gregory Macosko to serve as a member of the company's Board of Directors and as Chairman of the company's Audit Committee. The Board of Directors has determined that Mr. Macosko is (i) an independent director pursuant to the rules of the NASDAQ Stock Market, and (ii) an 'audit committee financial expert' as such term is defined in Item 407(d) of Regulation S-K promulgated by the Securities and Exchange Commission (SEC). Gregory Macosko is currently a member of the Board of Directors of Montrose Advisors, and an SEC-registered investment advisor. He also serves as a business advisor to the Board of Directors of Bioxiness Pharmaceuticals.

MusclePharm Strengthens Retail Presence with GNC

MusclePharm Corporation announced an expanded relationship with GNC to carry all of MusclePharm's brands -- MusclePharm(R) Hybrid and Core Series, Arnold Schwarzenegger Series(TM) and FitMiss(R) -- on a dedicated wall in all of GNC's U.S. corporate stores. The new initiative is expected to begin during MusclePharm's 2014 third quarter.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MSLP:US $11.00 USD -0.10

MSLP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Natural Grocers by Vitamin Cottage Inc $23.57 USD -0.13
USANA Health Sciences Inc $71.95 USD +2.37
Vitamin Shoppe Inc $42.69 USD -1.27
View Industry Companies
 

Industry Analysis

MSLP

Industry Average

Valuation MSLP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.8x
Price/Book 3.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MUSCLE PHARM CORP, please visit www.musclepharm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.